Showing results (111-120 of 144) with videos related to

Sort By:
Pageof 15
The Lancet. Respiratory Medicine|July 5, 2021
BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workersYaniv Lustig, Einav Sapir, Gili Regev-Yochay, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 27, 2021
Third dose of the BNT162b2 vaccine in heart transplant recipients: Immunogenicity and clinical experienceYael Peled, Eilon Ram, Jacob Lavee, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 19, 2024
Rapid molecular epidemiology investigations into two recent measles outbreaks in Israel detected from October 2023 to January 2024Efrat Bucris, Victoria Indenbaum, Tal Levin, et al.
The Lancet Regional Health. Europe|July 12, 2021
Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in IsraelGili Regev-Yochay, Sharon Amit, Moriah Bergwerk, et al.
Emerging Microbes & Infections|July 17, 2024
Numb-associated kinases regulate sandfly-borne Toscana virus entryYarden Moalem, Rodolfo Katz, Anand G Subramaniam, et al.
The New England Journal of Medicine|July 28, 2021
Covid-19 Breakthrough Infections in Vaccinated Health Care WorkersMoriah Bergwerk, Tal Gonen, Yaniv Lustig, et al.
Nature Communications|December 13, 2022
Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-upMichal Canetti, Noam Barda, Mayan Gilboa, et al.
Biosensors|July 25, 2025
Sensitivity and Cross-Reactivity Analysis of Serotype-Specific Anti-NS1 Serological Assays for Dengue Virus Using Optical Modulation BiosensingSophie Terenteva, Linoy Golani-Zaidie, Shira Avivi, et al.
The Journal of Infectious Diseases|December 1, 2021
Early Immunogenicity and Safety of the Third Dose of BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Among Adults Older Than 60 Years: Real-World ExperienceMayan Gilboa, Michal Mandelboim, Victoria Indenbaum, et al.
Vaccine|May 31, 2022
Robust antibody response after a third BNT162b2 vaccine compared to the second among immunocompromised and healthy individuals, a prospective longitudinal cohort studyShirley Shapiro Ben David, Barak Mizrahi, Daniella Rahamim-Cohen, et al.
Pageof 15